National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis

Chronic liver disease is a growing health concern, with limited access to liver transplants. This study addresses the urgent need for alternatives by exploring regenerative therapies, like G-CSF, to boost the liver's natural repair. The goal is to develop safe, effective, and accessible treatments for patients who cannot undergo transplant.

NCT Number	NCT07131280
Lead Sponsor	Institute of Liver and Biliary Sciences, India Collaborators: Indian Council of Medical Research
Conditions	Decompensated Cirrhosis
Enrollment	110 participants
Start Date	2025-09
Primary Completion	2031-07 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-20